The Use of Sucroferric Oxyhydroxide Prior to Sigmoidoscopy in Patients With End-Stage Kidney Disease: A Case Report.

ABSTRACT:

Rationale

Sucroferric oxyhydroxide is an iron-based phosphate-binding medication that has been approved for the treatment of hyperphosphatemia in patients with end-stage kidney disease. Given the low overall iron release from the polynuclear iron(III)-oxyhydroxide molecule, recommendations regarding its use prior to colonoscopy/sigmoidoscopy have not been developed.

Presenting concerns of the patient

A 51-year-old male with a known history of end-stage renal disease treated with hemodialysis was referred to Gastroenterology for consideration of colonoscopy to rule out malignancy because of a history of rectal bleeding. This was to be completed prior to proceeding with a living-donor kidney transplant.

Diagnoses

Flexible sigmoidoscopy done after non-diagnostic colonosc

SUBMITTER: Horwitz J 

PROVIDER: S-EPMC11406624 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature